Get the SPI Wire

Vistagen Therapeutics, Inc.

NASDAQ:VTGN
Annual Meeting

of Shareholders

MEETING DATE

09/10/2026
DEF 14A FILED
07/31/2026
PUBLISHED
07/31/2026 8:10 pm
TIME TO PUBLISH
08/02/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:VTGN · CUSIP 92840H400 · CLASS common stock · CIK 0001411685

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states four continuing directors are nominated for election at the Annual Meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Non-Binding Advisory Vote to Approve Executive Compensation
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the 2025 Say-on-Pay vote received over 97% support.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Ratification of the Appointment of KPMG LLP to Serve as the Company's Independent Registered Public Accounting Firm for the Current Fiscal Year
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states 100% of audit and non-audit services were pre-approved by the Audit Committee.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

9ae7238afdd601c14cb46be274ab7b639b61394a5264cf92ea9648a1e787277b

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates